Browse by author
Lookup NU author(s): Professor Jordi Diaz ManeraORCiD, Meredith JamesORCiD
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.Pompe disease is a rare, inherited metabolic disorder characterised by lysosomal acid alpha-glucosidase deficiency. The disease is classified into infantile-onset and late-onset forms and is treated with enzyme replacement therapy. Currently, there are no standardised clinical management guidelines for Pompe disease in the UK. An expert panel of nine healthcare professionals with expertise in caring for patients with Pompe disease was convened. A review of the literature was performed for an overview of the available evidence and to identify gaps. This was used to develop survey questions for the steering committee to answer based on their clinical experience. Statements were drafted based on answers and voted on anonymously by the experts before being discussed during two meetings to reach consensus. Consensus was reached on how to diagnose Pompe disease in adult and paediatric patients, evaluations to assess disease progression and treatment effect and long-term management. These are the first UK-specific guidelines describing clinical management of Pompe disease.
Author(s): Diaz-Manera J, Broomfield A, Davison J, Deegan P, Gould R, Geberhiwot T, James MK, Lilleker JB, Sharma R
Publication type: Article
Publication status: Published
Journal: BMJ Neurology Open
Year: 2025
Volume: 7
Issue: 2
Print publication date: 01/07/2025
Online publication date: 23/12/2025
Acceptance date: 19/11/2025
Date deposited: 12/01/2026
ISSN (electronic): 2632-6140
Publisher: BMJ Publishing Group
URL: https://doi.org/10.1136/bmjno-2025-001274
DOI: 10.1136/bmjno-2025-001274
Altmetrics provided by Altmetric
